Yıl: 2015 Cilt: 6 Sayı: 1 Sayfa Aralığı: 37 - 40 Metin Dili: Türkçe İndeks Tarihi: 29-07-2022

Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis

Öz:
Amaç: Bu çalışmanın amacı intertriginöz tinea pedis tedavisinde oral terbinafin ve itrakonazolun etkinliğinin ve güvenirliğinin değerlenmekti. Gereç veYöntem: Klinik ve mikolojik olarak intertriginöz tinea pedis tanısı konan 60hasta çalışmaya alındı. Hastalar iki gruba ayrıldı. Birinci grup iki hafta boyunca 250 mg oral terbinafin (n:30) aldı. İkinci grup yedi gün boyunca 200mg itrakonazol tedavisi aldı. İlk muayenede ve çalışmaya başladıktan sonraki 15, 30, 60ıncı günlerde semptom ve bulgular kliniksel olarak değerlendirildi ve mikolojik değerlendirme için örnek alındı. Bulgular: İlk muayeneden sonra kontrol muayenelerine gelmeyen 6 hasta çalışma dışında bırakıldı. Tedavinin etkinliği 15, 30, 60ıncı günlerde değerlendirildi. Birinci kontrolde terbinafin grubunda %57.1 ve itrakonazol grubunda %46.1 oranında semptomlarkayboldu. İkinci kontrolde terbinafin grubunda tedavi başarısı %82.1, itrakonazol grubunda %73.1 idi. 60ıncı günde kür oranları benzerdi (terbinafin için%89.3, itrakonazol için %84.6). İki grup arasında istatistiksel olarak anlamlıfark saptanmadı. Tartışma: İntertriginöz tinea pedis tedavisinde oral terbinafin ve itrakonazol benzer etkinlik ve tolerabiliteye sahiptir.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp

Tinea Pedis Tedavisinde Oral Terbinafin ve İtrakonazolun Karşılaştırılması

Öz:
Aim: The aim of this study was to evaluate the efficacy and safety of oralterbinafine and itraconazole in the treatment of the patients with interdigitaltinea pedis. Material and Method: A total 60 patients with clinically and my- cologically diagnosed as interdigital tinea pedis were enrolled to the study.Patients were divided into two groups. The first group received oral terbin- afine 250 mg/day for two weeks (n:30). The second group received itracon- azole 200 mg daily for 7 days (n:30). At the first visit and 15, 30, 60 daysafter the start of the study, signs and symptoms were assessed clinically andscales were taken for mycological assessments. Results: Six patients who didnot return after the first visit were excluded from the study (2 on terbinafine,4 on itraconazole). The effectiveness of therapy was evaluated at day 15, 30,60. Symptoms were absent in 57.1% of terbinafine group and 46.1% of theitraconazole group in the first control. The effectiveness of the terbinafinegroup was 82.1% and 73.1% of the itraconazole group in second control. Atday 60, the cure rates were similar (89.3% for terbinafine, 84.6% for itraconazole). No statistical significant differences between the two groups was observed (p>0.05). Discussion: Oral terbinafine and itraconazole have the sameeffectiveness and tolerability in the treatment of interdigital tinea pedis.
Anahtar Kelime:

Konular: Genel ve Dahili Tıp
Belge Türü: Makale Makale Türü: Araştırma Makalesi Erişim Türü: Erişime Açık
  • 1. Foster KW, Ghannoum MA, Elewski BE.Epidemiologic surveillance of cutaneo- us fungal infection in the United States from 1999 to 2002. J Am Acad Dermatol 2004;50(5):748-52.
  • 2. Perea S, Ramos MJ, Garau M, Gonzales A, Noriega AR, del Palacio A.Prevalence and risk factors of tineaunguium and tineapedis in the general population in Spain. J Clin Microbiol 2000;38(9):3226-30.
  • 3. Bonifaz A, Saúl A.Treatment of tineapedis with a single pulse of itraconazole. Eur J Dermatol 2002;12(2):157-9.
  • 4. Mat MC, İşçimen A, Tüzün Y.Yeni antifungal ajanlar. Turkderm 1992;26:113-20.
  • 5. Gupta AK, Sauder DN, Shear NH. Antifungal agents: an overview. Part I. J Am AcadDermatol 1994;30(5):677-98.
  • 6. Degreef HJ, DeDoncker PR. Current therapy of dermatophytosis. J Am Acad Dermatol 1994;31(3):25-30.
  • 7. Havlickova B, Czaika VA, Friedrich M. Epidemiological trends in skin mycoses worldwide. Mycoses 2008;51(Suppl. 4):2-15.
  • 8. Kiraz N, Metintas S, Oz Y, Koc F, KokuAksu EA, Kalyoncu C et al. The prevalence of tineapedis and tineamanuum in adults in rural areas in Turkey. Int J Environ Health Res 2010;20(5):379-86.
  • 9. Leyden J. Pharmacokinetics and pharmacology of terbinafine and itraconazole. J Am Acad Dermatol1998;38(5):42-7.
  • 10. Fernandez-Torres B, Carrillo AJ, Martin E, Del Palacio A, Moore MK, Valverde A et al. In vitro activities of 10 antifungal drugs against 508 dermatophyte strains. Antimicrob Agents Chemother 2001;45(9):2524-8.
  • 11. Hazneci E, Bayram N, Akı T, Doğan G. Yüzeyel mantar hastalıklarında önerdiğimiz tedavilerin retrospektif değerlendirmesi. Turkderm 2004;38(1):54-60.
  • 12. Gupta AK, Shear NH. Terbinafine: an update. J Am AcadDermatol 1997;37(6):979-88.
  • 13. Patel A, Brookman SD, Bullen MU, Marley J, Ellis DH, Williams T et al. Topical treatment of interdigitaltineapedis: terbinafine compared with clotrimazole. Australas J Dermatol 1999;40(4):197-200.
  • 14. Lesher JL Jr. Oral therapy of common superficial fungal infections of the skin. J Am Acad Dermatol 1999;40(6):31-4.
  • 15. Hazen KC. Fungicidal versus fungistatic activity of terbinafine and itraconazole: An in vitro comparison. J Am Acad Dermatol 1998;38(5):37-41.
  • 16. Jessup CJ, Warner J, Isham N, Hasan I, Ghannoum MA. Antifungal susceptibility testing of dermatophytes: establishing a medium for inducing conidial growth and evaluation of susceptibility of clinical isolates. J Clin Microbiol 2000;38(1):341-4.
  • 17. Sancak B, Ayhan M, Karaduman A, Arıkan S. Yenidoğanlarda nizole edilen ma- lassezia suşlarının ketokonazol, itrakonazol veterbinafine in vitro duyarlılığı. Mikrobiyol Bült 2005:39(3):301-8.
  • 18. De Keyser P, De Backer M, Massart DL, Westelinck KJ. Two-week oral treatment of tinea pedis, comparing terbinafine (250 mg/day) with itraconazole (100 mg/ day): a double-blind, multicentre study. Br J Dermatol 1994;130(Suppl. 43):22-5.
  • 19. Hazneci E, Oram Y, Yoloğlu S. Yüzeyel dermatofit enfeksiyonlarının tedavisinde itrakonazol ve terbinafinin karşılaştırması. Turkderm 1995;29(3):147-50.
  • 20. Sarıcaoğlu H, Tunalı Ş, Alpakut Ş, Özyıldırım R, Palalı Z. Onikomikoz tedavisinde terbinafin. Turkiye Klinikleri J Dermatol 1997;7(3):166-9.
  • 21. White JE, Perkins PJ, Evans EG.Successful 2-week treatment with terbi- nafine (Lamisil) for moccasin tineapedis and tineamanuum. Br J Dermatol 1991;125(3):260-2.
  • 22. Özgöztaşı O, Erbağcı Z, Kırtak N.Tineapedistedavisinde oral terbinafine. Turkderm 1995;29:105-8.
  • 23. Tausch I, Decroix J, Gwiezdzinski Z, Urbanowski S, Baran E, Ziarkiewicz M et al.Short-term itraconazole versus terbinafine in the treatment of tineapedis or manus. Int J Dermatol1998;37(2):140-2.
  • 24. Hay RJ, McGregor JM, Wuite J, Ryatt KS, Ziegler C, Clayton YM.A comparison of 2 weeks of terbinafine 250 mg/day with 4 weeks of itraconazole 100 mg/day in plantar-type tineapedis. Br J Dermatol 1995;132(4):604-8.
  • 25. Gupta AK, Doncker PD, Heremans A, Stoffels P, Piérard GE, Decroix J et al.Itraconazole for the treatment of tineapedis: a dosage of 400 mg/day given for 1 week is similar in efficacy to 100 or 200 mg/day given for 2 to 4 weeks. J Am AcadDermatol 1997;36(5):789-92.
APA BİLGİLİ M, SARAÇOĞLU Z, Yıldız H, ASLAN A, Sabuncu I (2015). Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis. , 37 - 40.
Chicago BİLGİLİ Memet Erşan,SARAÇOĞLU Zeynep Nurhan,Yıldız Hamza,ASLAN Abdurrahman,Sabuncu Ilham Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis. (2015): 37 - 40.
MLA BİLGİLİ Memet Erşan,SARAÇOĞLU Zeynep Nurhan,Yıldız Hamza,ASLAN Abdurrahman,Sabuncu Ilham Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis. , 2015, ss.37 - 40.
AMA BİLGİLİ M,SARAÇOĞLU Z,Yıldız H,ASLAN A,Sabuncu I Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis. . 2015; 37 - 40.
Vancouver BİLGİLİ M,SARAÇOĞLU Z,Yıldız H,ASLAN A,Sabuncu I Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis. . 2015; 37 - 40.
IEEE BİLGİLİ M,SARAÇOĞLU Z,Yıldız H,ASLAN A,Sabuncu I "Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis." , ss.37 - 40, 2015.
ISNAD BİLGİLİ, Memet Erşan vd. "Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis". (2015), 37-40.
APA BİLGİLİ M, SARAÇOĞLU Z, Yıldız H, ASLAN A, Sabuncu I (2015). Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis. Journal of Clinical and Analytical Medicine, 6(1), 37 - 40.
Chicago BİLGİLİ Memet Erşan,SARAÇOĞLU Zeynep Nurhan,Yıldız Hamza,ASLAN Abdurrahman,Sabuncu Ilham Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis. Journal of Clinical and Analytical Medicine 6, no.1 (2015): 37 - 40.
MLA BİLGİLİ Memet Erşan,SARAÇOĞLU Zeynep Nurhan,Yıldız Hamza,ASLAN Abdurrahman,Sabuncu Ilham Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis. Journal of Clinical and Analytical Medicine, vol.6, no.1, 2015, ss.37 - 40.
AMA BİLGİLİ M,SARAÇOĞLU Z,Yıldız H,ASLAN A,Sabuncu I Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis. Journal of Clinical and Analytical Medicine. 2015; 6(1): 37 - 40.
Vancouver BİLGİLİ M,SARAÇOĞLU Z,Yıldız H,ASLAN A,Sabuncu I Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis. Journal of Clinical and Analytical Medicine. 2015; 6(1): 37 - 40.
IEEE BİLGİLİ M,SARAÇOĞLU Z,Yıldız H,ASLAN A,Sabuncu I "Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis." Journal of Clinical and Analytical Medicine, 6, ss.37 - 40, 2015.
ISNAD BİLGİLİ, Memet Erşan vd. "Comparison of Oral Terbinafine with Itraconazole in the Treatment of Tinea Pedis". Journal of Clinical and Analytical Medicine 6/1 (2015), 37-40.